|
- 积分
- 3
- 威望
- 3
- 包包
- 15
|
A review of gene and stem cell therapy in cutaneous wound healing
4 ]$ ]& L" s- d+ J% L5 s7 a! l0 [A Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex
' e% b( o# }8 g, Z+ Y7 r O8 MAcute Complications of Stem Cell Transplant
8 C- U9 x& F* o8 L0 H, X3 k. \# F5 oAdhesion within the stem cell niches $ ?0 R! n! |) R1 |
Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma % Y& K8 R4 A. p% U4 y1 t( D
Beliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research 3 |% i, y# c7 W7 p1 \8 K! U- V+ k
bone-What is the true nature of the osteoblastic hematopoietic stem cell niche
4 P6 M* U4 [& Z7 C. a0 k( AApoptosis signaling in cancer stem cells 1 |: z! J% J4 {- M# w) ~0 D9 i6 b6 w
Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation ) I: N" Y; X2 Q. J+ E
Recurrence cancer stem cells
( n; W+ {# Y- f# m+ a2 C% CStem cells in melanoma development
8 T" K0 B5 `. h, n% xCompetitive Interactions Between Cells
. b* @: Y7 d$ r+ n1 x! c. aCord blood stem cells for hematopoietic stem cell transplantation in the UK 8 k+ T$ b$ h( [) T. [" u Y
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke ' G# `3 M; P( d; ^: y# s) p
Cardiac stem-progenitor cells, secreted proteins, and proteomics
% F: P& p7 x. e1 y) C, }Cardiovascular stem cells in regenerative medicine
$ E+ F6 c% p8 a6 D4 F4 M* BEndogenous stem cells in patients undergoing coronary artery bypass
0 [9 e6 s% U, B* |4 cEnhancing cardiac stem cell differentiation into cardiomyocytes 2 B! G8 E" j1 R& A* C
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods
+ |% \. \0 G- i7 |2 [( m" `Resident cardiac stem-progenitor cells for cardiac regeneration 8 A3 |* F5 Z! e2 G2 h* X2 J
S1+ Stem Cell Survival and Engraftment in the Infarcted Heart
$ H" G8 D, x( \- ~: @Stem cell engineering for treatment of heart diseases ! ~! G% d2 P$ O h* Z
Stem cell therapy in acute myocardial infarction ! y. R$ d% N( x1 Q, X
Stem Cell Therapy Is Proarrhythmic
; {( i: `+ J; c2 U hStem Cell Therapy-A Primer for Interventionalists and Imagers & s+ p! a" r7 I( |( E' `0 }, E
diabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes
7 n! `( J- G" y7 o% j* P+ fEmbryonic stem cells as a model for cardiac development and disease
/ O8 Z/ t5 ^2 d$ vEpigenetic dynamics of stem cells and cell lineage commitment + N: k8 L+ s3 B7 y- i# b2 O
Epileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection
! ~( T+ {! S' S8 {$ P9 QExpanding Indications for Stem Cell Transplantation
9 G# ]8 V/ `% V% O' f4 h; l( hFatal nephrotic syndrome complicating allogeneic stem cell transplantation
b* z- F+ n! q5 x6 @Growth Factors, Matrices, and Forces Combine and Control Stem Cells
6 Z6 g- i6 U7 |9 L; G6 k' n6 V6 YHematopoietic stem cell origin of adipocytes + A: v/ M& H D' p& g' ?0 j/ T2 d$ s
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis
* v8 c& q4 m# [, y$ J6 T( i2 WLong-term microcarrier suspension cultures of human embryonic stem cells
) @% q4 G$ B1 ?; d' Y* R |; f, _Microsphere-based tracing and molecular delivery in embryonic stem cells
$ ` @; b4 H: V6 x& hMicrospheres as a vehicle for biomolecule delivery to neural stem cells
* F1 m& a, D/ g" o4 g" m0 V( }! aNew insights into liver stem cells
" d9 G2 Y0 [ Q6 n4 b3 }A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
i. x- B8 Y ~9 W( E bRegeneration of the ischemic brain by engineered stem cells , ]- q _/ R4 l; {( C" e+ t, d& H0 [6 C
Stem cell-based cell replacement strategies for the central nervous system
/ x) m' p, m5 t7 |8 L, _Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
$ _0 _& I9 i; s+ W& v( g' C+ l6 U: @* qPeripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction ; ]( g J$ j5 ]3 m6 [0 u, I
Pluripotent stem cells as new drugs
9 v1 {+ o/ L! a. t' xregenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine ( i" J& w+ d" S
respir-Cell therapy approaches for lung diseases : k- C; K* t% ~9 }' e) |
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation 4 f+ a4 X; ]3 W/ | t: P
Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation ( m. u" V. M; I: m) L ?
Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
, J& w# O$ w7 S& Q3 kStatus of adult marrow stem cell biology 4 H& x# p# n7 C( I; r
Stem cell and genetic therapies for the fetus
6 r& D* r7 d8 T1 g/ EStem cell decision making and critical-like exploratory networks & X C, A+ V" s+ v s" n1 u
Stem Cell Therapy for Heart Failure 6 f' z, t& e! X
Stem Cell Therapy for the Kidney 7 T. R7 w( U! d9 O; s" f: J% G
Stem Cells and Liver Regeneration
% w1 W' t8 q# H/ ?) c7 L9 E$ \Stem cells, microenvironment mechanics, and growth factor activation b( l4 `# v$ {
Stem cells-The highs and lows of pluripotency " L) v3 h# Q# M, k- ]& p
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation , X& M7 }3 d9 M, ^# C
Survivorship Issues in Hematopoietic Stem Cell Transplantation
. O6 v: z1 `) e, D9 G* ~Telomere length maintenance in stem cell populations
# Z" i( x$ _6 I, r8 wTeratoma formation by human embryonic stem cells
6 Y4 n1 ]: R, S/ x& |3 \The Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation # A( p& v+ c$ A' I) x, k2 u# P
The Increasing Complexity of the Cancer Stem Cell Paradigm % f% V% d+ |: q* U% L/ }
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
_% Z# {2 q5 D) n: ^Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation
/ B, J3 m: }" o8 qVariation in the safety of induced pluripotent stem cell lines
# {: K( h @' }7 HA niche play for stem cells
; G- r$ v6 A9 u/ |; u0 ?. j! oA niche play for stem cells ' \4 S* _" E! _# a
A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells 1 Z" t5 W/ [! D. V) y: h) q
Acute Complications of Stem Cell Transplant 7 e* s% [# J2 O1 Y4 v( n
Adipose-Derived Stem Cells ! X ^/ i6 K |+ X
Adult neural stem cells in the mammalian central nervous system 4 |% G6 J/ k6 O
Apoptosis Signaling in Cancer Stem Cells
0 M% ?8 G, S0 a5 A3 i2 f5 \) ]Automated selection and collection of pluripotent stem cell colonies using the CellCelector
0 S0 y) S- F7 u; k+ E' LBCOR regulates mesenchymal stem cell function by epigenetic mechanisms $ R% Y' T, T' o4 }( [6 G- `
Bmi-1, stem cells and cancer ( u4 a6 i4 `4 C3 b1 n
cancer stem cell marker ) ~, T# H& B4 K S
Cancer stem cells 2 _) o: S+ k0 o4 m" b
Clinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases Q9 Y; s9 n3 ?* W' b* u7 W9 @
Competitive Interactions Between Cells-Death, Growth, and Geography 9 C5 ~' u1 n. c [
Potential novel pharmacological therapies for myocardial remodelling
4 X4 q; }) Y, N2 [0 kDisease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells * ~. v" [4 r. e0 o! m, R4 M
Elite and stochastic models for induced pluripotent stem cell generation ) ` v# _' }- c$ Q9 \
Embryonic stem (ES) cell-derived cardiomyocytes % @ b4 t0 k/ m0 s% h
Emerging Immunology of Stem Cell Transplantation
, l; ? @# w- F3 ~# Y9 H X2 [% lEthical Issues in Stem Cell Research ) J6 N6 u0 k3 q% l+ N
FDA Regulation of Stem Cell Based Products
5 j# e% W/ m8 W( IGrowth Factors, Matrices, and Forces Combine and Control Stem Cells
( o; C+ W9 G/ d5 D; a7 q; rHuman embryonic stem cells and cardiac repair
* x; U% i {+ M( Z# D0 VHuman Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair
2 w0 _# o; X5 Z8 u3 @' BHuman ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages
7 S7 s8 l$ ~8 N) H# {IFN-wakes up sleeping hematopoietic stem cells 7 I, x( h4 b( U" S4 O5 n3 {
Imaging Stem Cell Implant for Cellular-Based Therapies 0 r, |) U: ~1 N# N" S: T
Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy 3 C! u/ @( ^+ g' i# n6 f, t% F
Induced pluripotent stem cells and the stability of the differentiated state
- y4 F3 ^! B& u3 g+ R9 bInstructing an Embryonic Stem Cell-Derived Oocyte Fate
# s8 A' U; U8 D% s6 R6 v' TMedical Innovation Versus Stem Cell Tourism 0 D! B. Q9 H- K$ I7 J' I* h+ D0 i; v! _
In Search of Adrenocortical Stem and Progenitor Cells 2 X, I* v! V4 Y& E3 l% v- E
Neural stem cells aplenty
# V$ j" a9 a0 j# O$ i) i" iPancreatic cancer stem cells 5 [0 X# {0 v% {6 H0 S
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
+ i! f( S- {* JPsychological Issues of Stem Cell Transplant
+ {, ~" N7 {7 N2 uRegeneration of the ischemic brain by engineered stem cells
7 p& h2 e1 k6 X+ Q# E3 O; ?0 jRegulatory circuits underlying pluripotency and reprogramming
) o4 w5 b# l% h# P( |4 O) Yrespir-Cell therapy approaches for lung diseases
! H1 T$ R8 t' m3 v9 IRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation 0 u9 r( ], X) y$ s5 U
specific microRNAs promote induced pluripotency
" U7 n9 E; e* b4 _7 OStem Cell Therapy for the Kidney & _6 @9 R3 N n
stem cell therapy in cutaneous wound healing
4 T; p- v6 t2 P1 ~Stem cell therapy perspectives for type 1 diabetes 5 H$ a# c1 H/ s6 v
Stem Cells and Liver Regeneration + K7 m. f Q0 }: }
Stem cells based transplantation for cardiovascular diseases in China
. t" z4 a# |. y1 n$ o* QStem-cell therapy faces more scrutiny in China & T% D# x, f% A/ }9 f% j" t
Steps to the Clinic
0 L6 ^/ ^( v, B {7 q2 YStepwise differentiation of pluripotent stem cells into retinal cells " B7 Z: e* W1 w- p& o( ^
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche : Q, L" w0 L: P
The Increasing Complexity of the Cancer Stem Cell Paradigm ^5 o0 V# j0 b3 a7 f5 d, }
The NIH Draft Guidelines on Human Stem Cell Research
& s+ }8 A7 w* B$ O$ RThe pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting , f6 `- b4 N' k5 K; B5 M+ O
The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair , F8 P/ L" I w9 m* b0 c( W
The tumor stem cell concept
0 S, g2 d. T8 F5 G& }" wUmbilical cord blood stem cells-Towards a proteomic approach ) t3 i* f4 W6 e a4 V
US regulator wades into stem cell therapies for heart disease
- w- B- b. | K. \ KApoptosis Signaling in Cancer Stem Cells 9 o4 b7 K% J) @0 q; ]8 O
Pancreatic cancer stem cells
, Q- F2 e/ \+ N9 d& ?4 GAcute Complications of Stem Cell Transplant ) z3 I- [/ J* p$ ]$ I+ U8 ^
Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma - }) ]& w/ x: W; h4 w3 E( p: [
Deconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine ' u! ~2 u) _$ E' C
Emerging Immunology of Stem Cell Transplantation & X3 `/ h4 y0 B8 B) t2 Y( K# j
Management Issues In Hematopoietic Stem Cell Transplantation
! a" k: E& P& i6 G. X8 @& RPsychological Issues of Stem Cell Transplant
& q5 O" B6 T. |- F; c$ k5 rThe NIH Draft Guidelines on Human Stem Cell Research * e2 z0 L% _7 R! `# C
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis , m% }# r- V' a" O+ @/ e- z
Bone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction # |( M+ {& T" ^
Embryonic stem (ES) cell-derived cardiomyocytes 6 P: b+ j8 G" C/ P
Embryonic stem cells as a model for cardiac development and disease 3 f* Q9 T5 p/ R/ {/ R2 m* S8 c
Endogenous stem cells in patients undergoing coronary artery bypass graft surgery 6 @) U1 f3 C- q* K* \
Human embryonic stem cells and cardiac repair
6 G( ]. o9 Z5 H( y0 [/ ^Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction
) i* {$ O- b9 v8 [* F, Q4 ~Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair , V3 I- v+ a1 v. E2 A
Stem Cell Therapy for Heart Failure
7 R: T' Q& Y% U0 HEpithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation
8 L2 v4 J+ L. j! L2 K) mFull text access provided to Peking university 9 D' f8 Z- m4 a% @5 z4 T2 W. }
Improving stem cell mobilization strategies-future directions * J: z% L3 w7 x8 @
Induced pluripotent stem cells from a spinal muscular atrophy patient
7 d& m4 t0 ]! p. Y! d4 U, E! lInduced pluripotent stem cells-current progress and potential for regenerative medicine
z3 @5 Y) X( D; ~! O, X; zInterferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion
% A) Z: V0 i4 j9 W- `0 hLow-risk reprogramming 4 K6 B& D( C" u3 f" \9 s8 M$ m
Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells
7 `. O, q+ m" m% h4 n3 D: bpiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells {) S9 R( M' }9 e+ G' {8 S, k
Pluripotent stem cells as new drugs 4 l& L7 F( ]& c' d6 O* J+ x
proteome-Umbilical cord blood stem cells-Towards a proteomic approach
3 S% ^/ ~" K4 c- G9 b9 {- HRegeneration of the ischemic brain by engineered stem cells ' ^' m* B( |6 d0 g
Researchers Generally Happy With Final Stem Cell Rules - h" f9 Q% y( {, G2 f
Stem Cell Niche $ @9 P% r9 f- x$ z, m/ T
Stem cell therapy perspectives for type 1 diabetes
4 z/ v; T( Q3 ]+ I3 @Stem Cells and Liver Regeneration . |7 A$ \: Y! { y
Stem cells-Fast and furious 6 l5 u# ^2 H6 n* b
Survivorship Issues in Hematopoietic Stem Cell Transplantation ; I! l. j; {: f( W1 s. F" f
The NIH Draft Guidelines on Human Stem Cell Research ) M- ?( x% W2 P# h6 A
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases
- ^. o4 j5 z3 aUS stem-cell research expands
2 g |2 r3 X, R: M1 BVirus-free induction of pluripotency and subsequent excision of reprogramming factors 3 |6 e& o+ z8 a* m
Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin |
|
发表于 2009-10-29 19:08
